---
title: "Edding Genor Group Holdings (6998) stock and investor profile"
url: "https://aibio.space/companies/edding-genor/"
publisher: "aibio.space (Biotech Investor Relations News)"
summary: "Edding Genor Group Holdings Limited (HKEX: 6998), China. The directory classifies it as Biotechnology."
---

6998 Edding Genor Group Holdings Limited HKEX · China

# Edding Genor Group Holdings (6998) news

Edding Genor Group Holdings Limited is a public biotech or pharmaceutical company listed on HKEX under the ticker 6998, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

## Latest Edding Genor Group Holdings news

We have not published a story on Edding Genor Group Holdings yet. When there is news, it will appear here.

## Edding Genor Group Holdings at a glance

- **Ticker**: 6998

- **Listing**: HKEX

- **Country**: China

### Related companies

- [Kintor Pharmaceutical](https://aibio.space/companies/kintor-pharmaceutical/) HKEX: 9939
- [Sinocelltech Group](https://aibio.space/companies/sinocelltech/) SSE: 688520
- [Shenzhen Kangtai Biological Products Co.](https://aibio.space/companies/shenzhen-kangtai-biological-products/) SZSE: 300601
- [Medtide](https://aibio.space/companies/medtide/) HKEX: 3880
- [Pacific Shuanglin Bio-pharmacy Co.](https://aibio.space/companies/pacific-shuanglin-bio-pharmacy/) SZSE: 000403
- [Boji Medical Technology Co.](https://aibio.space/companies/boji-medical-technology/) SZSE: 300404
- [Shanghai ZJ Bio-Tech Co.](https://aibio.space/companies/shanghai-zj-bio-tech/) SSE: 688317
- [Shanghai RAAS Blood Products Co.](https://aibio.space/companies/shanghai-raas-blood-products/) SZSE: 002252

### Also on HKEX

- [Suzhou Ribo Life Science Co.](https://aibio.space/companies/suzhou-ribo-life-science/) 6938
- [Kintor Pharmaceutical](https://aibio.space/companies/kintor-pharmaceutical/) 9939
- [JW (Cayman) Therapeutics Co.](https://aibio.space/companies/jw-cayman-therapeutics/) 2126
- [Shanghai Henlius Biotech](https://aibio.space/companies/shanghai-henlius-biotech/) 2696
- [Laekna](https://aibio.space/companies/laekna/) 2105
- [China Resources Pharmaceutical Group](https://aibio.space/companies/china-resources-pharmaceutical/) 3320

## Questions about Edding Genor Group Holdings

What is the ticker symbol of Edding Genor Group Holdings?

Edding Genor Group Holdings Limited trades under the ticker 6998 on HKEX.

Where is Edding Genor Group Holdings listed?

Edding Genor Group Holdings Limited is listed on HKEX.

Which country or territory is Edding Genor Group Holdings listed under?

Our directory records Edding Genor Group Holdings Limited under China.

What does Edding Genor Group Holdings do?

Our directory classifies Edding Genor Group Holdings Limited as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of Edding Genor Group Holdings?

The ISIN recorded for Edding Genor Group Holdings Limited is KYG3871A1004.

Does aibio.space cover Edding Genor Group Holdings?

aibio.space lists Edding Genor Group Holdings Limited among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Edding Genor Group Holdings?

Companies in our directory listed in the same country and business area as Edding Genor Group Holdings: Kintor Pharmaceutical, Sinocelltech Group, Shenzhen Kangtai Biological Products Co., Medtide, Pacific Shuanglin Bio-pharmacy Co., Boji Medical Technology Co..

## Investor discussion: Edding Genor Group Holdings

Members talk about Edding Genor Group Holdings (6998). Reader posts, not aibio.space reporting, and not investment advice.

Rules

1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
2. **Say whether you hold the stock.** Every post states long, short or no position.
3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you.
4. **No buy or sell calls and no price targets.**
5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them.
6. **No personal details and no spam.** No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion).

## Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Edding Genor Group Holdings, newest first. Each line links the filing it comes from.

1. 2026-07-16 Mergers Transaction under the Listing Rules: DISCLOSEABLE TRANSACTION - DISPOSAL OF EQUITY INTEREST IN CANDID THERAPEUTICS, INC.. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0716/2026071601375.pdf)
2. 2026-02-03 Listings Share consolidation: CHANGE OF COMPANY NAME AND STOCK SHORT NAME. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0203/2026020302134.pdf)
3. 2025-12-29 Mergers Transaction under the Listing Rules: ANNOUNCEMENT - (1) COMPLETION OF VERY SUBSTANTIAL ACQUISITION AND CONNECTED TRANSACTION INVOLVING ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE; (2) REVERSE TAKEOVER; (3) THE ONE-OFF SHARE OPTION PLAN; (4) CHANGE OF COMPANY NAME; (5) REMOVAL OF STOCK MARKER; (6) CHANGE IN THE COMPOSITION OF THE BOARD; (7) CHANGE OF AUTHORISED REPRESENTATIVES AND AGENT FOR THE SERVICES OF PROCESS IN HONG KONG; (8) CHANGE OF JOINT COMPANY SECRETARIES AND (9)CHANGE OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1230/2025123000025.pdf)
4. 2025-12-22 Mergers Transaction under the Listing Rules: ANNOUNCEMENT ON (1) POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 22 DECEMBER 2025; (2) GRANT OF WHITEWASH WAIVER AND CONSENT TO SPECIAL DEAL; AND (3) INCREASE IN AUTHORISED SHARE CAPITAL OF THE COMPANY. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1222/2025122200560.pdf)
5. 2025-12-04 Mergers Transaction under the Listing Rules: (1) VERY SUBSTANTIAL ACQUISITION AND CONNECTED TRANSACTION INVOLVING ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE; (2) REVERSE TAKEOVER INVOLVING THE NEW LISTING APPLICATION; (3) APPLICATION FOR WHITEWASH WAIVER; (4) SPECIAL DEAL; (5) PROPOSED CHANGE OF COMPANY NAME; (6) PROPOSED INCREASE IN AUTHORISED SHARE CAPITAL OF THE COMPANY; AND (7) PROPOSED ADOPTION OF THE ONE-OFF SHARE OPTION PLAN; AND DESPATCH OF CIRCULAR. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1204/2025120402588.pdf)
6. 2025-12-04 Mergers Transaction under the Listing Rules: (1) VERY SUBSTANTIAL ACQUISITION AND CONNECTED TRANSACTION INVOLVING ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE; (2) REVERSE TAKEOVER INVOLVING THE NEW LISTING APPLICATION; (3) APPLICATION FOR WHITEWASH WAIVER; (4) SPECIAL DEAL IN RELATION TO THE RETENTION PLAN OF THE SHAREHOLDER PERSONNEL; (5) PROPOSED CHANGE OF COMPANY NAME; (6) PROPOSED INCREASE IN AUTHORISED SHARE CAPITAL OF THE COMPANY; (7) PROPOSED ADOPTION OF THE ONE-OFF SHARE OPTION PLAN; AND (8) NOTICE OF EGM. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1204/2025120402472.pdf)
7. 2025-11-27 Mergers Transaction under the Listing Rules: MONTHLY UPDATE ON (1) VERY SUBSTANTIAL ACQUISITION AND CONNECTED TRANSACTION INVOLVING ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE; (2) REVERSE TAKEOVER INVOLVING THE NEW LISTING APPLICATION; (3) APPLICATION FOR WHITEWASH WAIVER; (4) SPECIAL DEAL; (5) PROPOSED CHANGE OF COMPANY NAME; (6) PROPOSED INCREASE IN AUTHORISED SHARE CAPITAL OF THE COMPANY; AND (7) PROPOSED ADOPTION OF THE ONE-OFF SHARE OPTION PLAN; AND DELAY IN DESPATCH OF CIRCULAR. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1127/2025112701508.pdf)
8. 2025-10-27 Mergers Transaction under the Listing Rules: MONTHLY UPDATE ON (1) VERY SUBSTANTIAL ACQUISITION AND CONNECTED TRANSACTION INVOLVING ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE; (2) REVERSE TAKEOVER INVOLVING THE NEW LISTING APPLICATION; (3) APPLICATION FOR WHITEWASH WAIVER; (4) SPECIAL DEAL; (5) PROPOSED CHANGE OF COMPANY NAME; (6) PROPOSED INCREASE IN AUTHORISED SHARE CAPITAL OF THE COMPANY; AND (7) PROPOSED ADOPTION OF THE ONE-OFF SHARE OPTION PLAN; AND DELAY IN DESPATCH OF CIRCULAR. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1027/2025102701472.pdf)
9. 2025-09-25 Mergers Transaction under the Listing Rules: MONTHLY UPDATE ON (1) VERY SUBSTANTIAL ACQUISITION AND CONNECTED TRANSACTION INVOLVING ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE; (2) REVERSE TAKEOVER INVOLVING THE NEW LISTING APPLICATION; (3) APPLICATION FOR WHITEWASH WAIVER; (4) SPECIAL DEAL; (5) PROPOSED CHANGE OF COMPANY NAME; (6) PROPOSED INCREASE IN AUTHORISED SHARE CAPITAL OF THE COMPANY; AND (7) PROPOSED ADOPTION OF THE ONE-OFF SHARE OPTION PLAN. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0925/2025092502122.pdf)
10. 2025-08-25 Mergers Transaction under the Listing Rules: MONTHLY UPDATE ON (1) VERY SUBSTANTIAL ACQUISITION AND CONNECTED TRANSACTION INVOLVING ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE; (2) REVERSE TAKEOVER INVOLVING THE NEW LISTING APPLICATION; (3) APPLICATION FOR WHITEWASH WAIVER; (4) SPECIAL DEAL; (5) PROPOSED CHANGE OF COMPANY NAME; (6) PROPOSED INCREASE IN AUTHORISED SHARE CAPITAL OF THE COMPANY; AND (7) PROPOSED ADOPTION OF THE ONE-OFF SHARE OPTION PLAN. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0825/2025082501568.pdf)
11. 2025-07-25 Mergers Transaction under the Listing Rules: MONTHLY UPDATE ON (1) VERY SUBSTANTIAL ACQUISITION AND CONNECTED TRANSACTION INVOLVING ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE; (2) REVERSE TAKEOVER INVOLVING THE NEW LISTING APPLICATION; (3) APPLICATION FOR WHITEWASH WAIVER; (4) SPECIAL DEAL; (5) PROPOSED CHANGE OF COMPANY NAME; (6) PROPOSED INCREASE IN AUTHORISED SHARE CAPITAL OF THE COMPANY; AND (7) PROPOSED ADOPTION OF THE ONE-OFF SHARE OPTION PLAN. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0725/2025072500801.pdf)
12. 2025-06-26 Mergers Transaction under the Listing Rules: FURTHER DELAY IN DESPATCH OF THE CIRCULAR IN RELATION TO - (1) VERY SUBSTANTIAL ACQUISITION INVOLVING ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE; (2) REVERSE TAKEOVER INVOLVING THE NEW LISTING APPLICATION; (3) APPLICATION FOR WHITEWASH WAIVER; (4) SPECIAL DEAL; (5) PROPOSED CHANGE OF COMPANY NAME; (6) PROPOSED INCREASE IN AUTHORISED SHARE CAPITAL OF THE COMPANY; AND (7) PROPOSED ADOPTION OF THE ONE-OFF SHARE OPTION PLAN. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0626/2025062600764.pdf)
13. 2025-06-13 Mergers Transaction under the Listing Rules: MONTHLY UPDATE ON (1) VERY SUBSTANTIAL ACQUISITION AND CONNECTED TRANSACTION INVOLVING ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE; (2) REVERSE TAKEOVER INVOLVING THE NEW LISTING APPLICATION; (3) APPLICATION FOR WHITEWASH WAIVER; (4) SPECIAL DEAL; (5) PROPOSED CHANGE OF COMPANY NAME; (6) PROPOSED INCREASE IN AUTHORISED SHARE CAPITAL OF THE COMPANY; AND (7) PROPOSED ADOPTION OF THE ONE-OFF SHARE OPTION PLAN. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0613/2025061300836.pdf)
14. 2025-05-14 Mergers Transaction under the Listing Rules: MONTHLY UPDATE ON (1) VERY SUBSTANTIAL ACQUISITION INVOLVING ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE; (2) REVERSE TAKEOVER INVOLVING THE NEW LISTING APPLICATION; (3) APPLICATION FOR WHITEWASH WAIVER; (4) SPECIAL DEAL; (5) PROPOSED CHANGE OF COMPANY NAME; (6) PROPOSED INCREASE IN AUTHORISED SHARE CAPITAL OF THE COMPANY; AND (7) PROPOSED ADOPTION OF THE ONE-OFF SHARE OPTION PLAN. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0515/2025051500015.pdf)
15. 2025-04-15 Mergers Transaction under the Listing Rules: FILING OF THE NEW LISTING APPLICATION. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0415/2025041501803.pdf)
16. 2025-03-24 Mergers Transaction under the Listing Rules: MONTHLY UPDATE ON (1) VERY SUBSTANTIAL ACQUISITION INVOLVING ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE; (2) REVERSE TAKEOVER INVOLVING THE NEW LISTING APPLICATION; (3) APPLICATION FOR WHITEWASH WAIVER; (4) SPECIAL DEAL; (5) PROPOSED CHANGE OF COMPANY NAME; (6) PROPOSED INCREASE IN AUTHORISED SHARE CAPITAL OF THE COMPANY; AND (7) PROPOSED ADOPTION OF THE ONE-OFF SHARE OPTION PLAN. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0325/2025032500015.pdf)
17. 2025-02-25 Mergers Transaction under the Listing Rules: MONTHLY UPDATE ON (1) VERY SUBSTANTIAL ACQUISITION INVOLVING ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE; (2) REVERSE TAKEOVER INVOLVING THE NEW LISTING APPLICATION; (3) APPLICATION FOR WHITEWASH WAIVER; (4) SPECIAL DEAL; (5) PROPOSED CHANGE OF COMPANY NAME; (6) PROPOSED INCREASE IN AUTHORISED SHARE CAPITAL OF THE COMPANY; AND (7) PROPOSED ADOPTION OF THE ONE-OFF SHARE OPTION PLAN; AND DELAY IN DESPATCH OF CIRCULAR. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0225/2025022500620.pdf)
18. 2025-01-24 Mergers Transaction under the Listing Rules: MONTHLY UPDATE ON (1) VERY SUBSTANTIAL ACQUISITION INVOLVING ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE; (2) REVERSE TAKEOVER INVOLVING THE NEW LISTING APPLICATION; (3) APPLICATION FOR WHITEWASH WAIVER; (4) SPECIAL DEAL; (5) PROPOSED CHANGE OF COMPANY NAME; (6) PROPOSED INCREASE IN AUTHORISED SHARE CAPITAL OF THE COMPANY; AND (7) PROPOSED ADOPTION OF THE ONE-OFF SHARE OPTION PLAN; AND BUSINESS UPDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0124/2025012401221.pdf)
19. 2024-12-27 Mergers Transaction under the Listing Rules: MONTHLY UPDATE ON (1) VERY SUBSTANTIAL ACQUISITION INVOLVING ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE; (2) REVERSE TAKEOVER INVOLVING THE NEW LISTING APPLICATION; (3) APPLICATION FOR WHITEWASH WAIVER; (4) SPECIAL DEAL; (5) PROPOSED CHANGE OF COMPANY NAME; (6) PROPOSED INCREASE IN AUTHORISED SHARE CAPITAL OF THE COMPANY; AND (7) PROPOSED ADOPTION OF THE ONE-OFF SHARE OPTION PLAN. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2024/1227/2024122701382.pdf)
20. 2024-11-28 Mergers Transaction under the Listing Rules: MONTHLY UPDATE ON (1) VERY SUBSTANTIAL ACQUISITION INVOLVING ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE; (2) REVERSE TAKEOVER INVOLVING THE NEW LISTING APPLICATION; (3) APPLICATION FOR WHITEWASH WAIVER; (4) SPECIAL DEAL; (5) PROPOSED CHANGE OF COMPANY NAME; (6) PROPOSED INCREASE IN AUTHORISED SHARE CAPITAL OF THE COMPANY; AND (7) PROPOSED ADOPTION OF THE ONE-OFF SHARE OPTION PLAN. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2024/1128/2024112801539.pdf)
21. 2024-11-26 Mergers Transaction under the Listing Rules: APPOINTMENT OF INDEPENDENT FINANCIAL ADVISER. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2024/1126/2024112601146.pdf)

## Press releases

Headlines of Edding Genor Group Holdings's own announcements, newest first. Each opens the full release on the newswire that carried it.

1. 2026-10-23 HKEXnews [VOLUNTARY ANNOUNCEMENT - FIRST-IN-HUMAN PHASE I STUDY DATA OF GB268 PRESENTED AT THE ESMO CONGRESS 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1023/2026102301661.pdf)
2. 2026-10-11 HKEXnews [VOLUNTARY ANNOUNCEMENT - IND APPROVAL FROM THE NMPA FOR PHASE II CLINICAL TRIAL OF GB268 IN COLORECTAL CANCER](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1011/2026101100011.pdf)
3. 2026-08-31 HKEXnews [SHARE INCREASING PLAN BY THE CHAIRMAN OF THE BOARD AND ON-MARKET SHARE REPURCHASE UNDER THE REPURCHASE MANDATE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0831/2026083102969.pdf)
4. 2026-08-28 HKEXnews [INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0828/2026082802648.pdf)
5. 2026-08-21 HKEXnews [PROFIT WARNING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0821/2026082101971.pdf)
6. 2026-08-06 HKEXnews [VOLUNTARY ANNOUNCEMENT - COMPLETION OF THE FIRST SUBJECT DOSING IN PHASE IB/II CLINICAL TRIAL OF GB268](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0806/2026080602069.pdf)
7. 2026-08-05 HKEXnews [UPDATE ON CONTINUING CONNECTED TRANSACTION IN RELATION TO THE SUB-LICENSING ARRANGEMENT OF JING ZHU DA](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0805/2026080502025.pdf)
8. 2026-07-16 HKEXnews [DISCLOSEABLE TRANSACTION - DISPOSAL OF EQUITY INTEREST IN CANDID THERAPEUTICS, INC.](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0716/2026071601375.pdf)
9. 2026-07-07 HKEXnews [VOLUNTARY ANNOUNCEMENT - ON-MARKET SHARE REPURCHASE UNDER THE REPURCHASE MANDATE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0707/2026070701961.pdf)
10. 2026-07-02 HKEXnews [VOLUNTARY ANNOUNCEMENT - PHASE IB/II CLINICAL TRIAL OF GB268 OBTAINED IND APPROVAL BY NMPA](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0702/2026070203959.pdf)
11. 2026-06-26 HKEXnews [POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 26 JUNE 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0626/2026062602259.pdf)
12. 2026-06-10 HKEXnews [VOLUNTARY ANNOUNCEMENT - SHARE INCREASING PLAN BY THE CHAIRMAN OF THE BOARD](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0610/2026061001320.pdf)
13. 2026-05-13 HKEXnews [CHANGE OF JOINT COMPANY SECRETARY](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0513/2026051301133.pdf)
14. 2026-05-04 HKEXnews [VOLUNTARY ANNOUNCEMENT - LATEST UPDATE ON COOPERATION WITH CANDID THERAPEUTICS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0504/2026050403568.pdf)
15. 2026-04-15 HKEXnews [NOTICE OF ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0415/2026041500380.pdf)
16. 2026-03-27 HKEXnews [(1) ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2025; (2) CHANGE OF EXECUTIVE DIRECTOR; AND (3) CHANGE OF CHIEF EXECUTIVE OFFICER](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0327/2026032703430.pdf)
17. 2026-03-03 HKEXnews [VOLUNTARY ANNOUNCEMENT - LATEST UPDATE ON COOPERATION WITH NANOPEPTIDE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0303/2026030302336.pdf)
18. 2026-02-09 HKEXnews [VOLUNTARY ANNOUNCEMENT - COMPLETION OF THE FIRST SUBJECT DOSING IN PHASE II CLINICAL TRIAL OF EDP167](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0209/2026020900097.pdf)
19. 2026-02-03 HKEXnews [CHANGE OF COMPANY NAME AND STOCK SHORT NAME](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0203/2026020302134.pdf)
20. 2026-01-22 HKEXnews [VOLUNTARY ANNOUNCEMENT - ON-MARKET SHARE REPURCHASE UNDER THE REPURCHASE MANDATE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0122/2026012201303.pdf)

## Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open HKEX:6998 on TradingView](https://www.tradingview.com/symbols/HKEX-6998/).

## Listing details

Edding Genor Group Holdings Limited is a public biotech or pharmaceutical company listed on HKEX under the ticker 6998, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

- **Company**: Edding Genor Group Holdings Limited

- **Ticker**: 6998

- **Listing**: HKEX

- **Country or territory**: China

- **Business scope**: Biotechnology

- **ISIN**: KYG3871A1004

- **Last quote in directory**: 2026-10-22

- **Directory source**: [Listing page](https://www.tradingview.com/symbols/HKEX-6998/)

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/).

Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/).

Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update)

---
Source page: https://aibio.space/companies/edding-genor/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Edding Genor Group Holdings (6998) stock and investor profile", 2026-10-31, https://aibio.space/companies/edding-genor/